Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Hotspot Therapeutics received early financing of $45.0M on 2018-07-17.
| Series | Round size | Date |
|---|---|---|
| Series A | $45M | 07/2018 |
| Series B | $65M | 05/2020 |
| Series C | $100M | 11/2021 |
| Investors | Security type |
|---|---|
| Atlas Venture | Series A |
| SOFINNOVA PARTNERS | Series A |
| SR One | Series B |
| Tekla Capital Management | Series B |
| BRACE PHARMA CAPITAL | Series B |
| MRL Ventures Fund LLC | Series B |
| Solasta Ventures | Series B |
| Atlas Venture | Series B |
| SOFINNOVA PARTNERS | Series B |
| B Capital Group | Series C |
| SR One | Series C |
| Monashee Investment Management LLC | Series C |
| Pavilion Capital | Series C |
| CaaS Capital Management | Series C |
| Atlas Venture | Series C |
| LSP | Series C |
| PIVOTAL BIOVENTURE PARTNERS | Series C |
| SOFINNOVA PARTNERS | Series C |
| Revelation Partners | Series C |
Hotspot Therapeutics's top competitor, XORTX Therapeutics, earned an annual revenue of $6.2B.
Hotspot Therapeutics's smallest competitor is Edgewise Therapeutics with revenue of $30.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Rgenta Therapeutics | - | $41,000 | 5 | - |
| XORTX Therapeutics | - | $6.2B | 2 | - |
| Groove Biopharma | - | $260,000 | 6 | - |
| WindMIL Therapeutics | - | $530,000 | 30 | - |
| CAMP4 Therapeutics | - | $890,000 | 46 | - |
| Arvinas Inc. | - | $263.4M | 83 | - |
| Arcturus Therapeutics | - | $152.3M | 150 | - |
| Edgewise Therapeutics | - | $30,000 | 45 | - |
| Mersana Therapeutics | - | $40.5M | 169 | - |
Zippia gives an in-depth look into the details of Hotspot Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Hotspot Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Hotspot Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Hotspot Therapeutics. The data presented on this page does not represent the view of Hotspot Therapeutics and its employees or that of Zippia.
Hotspot Therapeutics may also be known as or be related to HotSpot Therapeutics, HotSpot Therapeutics Inc, HotSpot Therapeutics, Inc and Hotspot Therapeutics.